Effects of Medicare Part D coverage gap closure on utilization of branded and generic drugs
Sign Up to like & getrecommendations! Published in 2022 at "Health Economics"
DOI: 10.1002/hec.4637
Abstract: Abstract The Affordable Care Act included a provision to gradually eliminate the Medicare prescription drug coverage gap between 2011 and 2020, which substantially lower medication costs in the gap. Using 2007–2016 Medicare claims data, we… read more here.
Keywords: generic drugs; branded generic; coverage gap; gap ... See more keywords